Cargando…
N-Heterocyclic borneol derivatives as inhibitors of Marburg virus glycoprotein-mediated VSIV pseudotype entry
There is currently no approved antiviral therapy for treatment of Marburg virus disease (MVD). Although filovirus infection outbreaks are quite rare, the high mortality rates in such outbreaks make the development of anti-filoviral drugs an important goal of medical chemistry and virology. Here, we...
Autores principales: | Kononova, A. A., Sokolova, A. S., Cheresiz, S. V., Yarovaya, O. I., Nikitina, R. A., Chepurnov, A. A., Pokrovsky, A. G., Salakhutdinov, N. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072471/ https://www.ncbi.nlm.nih.gov/pubmed/30108738 http://dx.doi.org/10.1039/c7md00424a |
Ejemplares similares
-
Synthesis and in vitro study of novel borneol derivatives as potent inhibitors of the influenza A virus
por: Sokolova, A. S., et al.
Publicado: (2017) -
Borneol Ester Derivatives as Entry Inhibitors of a Wide Spectrum of SARS-CoV-2 Viruses
por: Yarovaya, Olga I., et al.
Publicado: (2022) -
Quaternary ammonium salts based on (-)-borneol as effective inhibitors of influenza virus
por: Sokolova, Anastasiya S., et al.
Publicado: (2021) -
Discovery of N-Containing (-)-Borneol Esters as Respiratory Syncytial Virus Fusion Inhibitors
por: Sokolova, Anastasiya S., et al.
Publicado: (2022) -
Synthesis of N-heterocyclic amides based on (+)-camphoric acid and study of their antiviral activity and pharmacokinetics
por: Yarovaya, O. I., et al.
Publicado: (2023)